Vande Woude GF - Search Results

1

HGF/SF-met signaling in the control of branching morphogenesis and invasion.

Zhang YW, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. J Cell Biochem. 2003 Feb 1;88(2):408-17. doi: 10.1002/jcb.10358. J Cell Biochem. 2003. PMID: 12520544 Review.

2

Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.

Zhang YW, Wang LM, Jove R, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. Oncogene. 2002 Jan 10;21(2):217-26. doi: 10.1038/sj.onc.1205004. Oncogene. 2002. PMID: 11803465

3

Met decoys: will cancer take the bait?

Zhang YW, Graveel C, Shinomiya N, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. Cancer Cell. 2004 Jul;6(1):5-6. doi: 10.1016/j.ccr.2004.07.003. Cancer Cell. 2004. PMID: 15261136 Free article.

4

RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival.

Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF. Shinomiya N, et al. Among authors: vande woude gf. Cancer Res. 2004 Nov 1;64(21):7962-70. doi: 10.1158/0008-5472.CAN-04-1043. Cancer Res. 2004. PMID: 15520203

5

Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor.

Zhang YW, Su Y, Lanning N, Gustafson M, Shinomiya N, Zhao P, Cao B, Tsarfaty G, Wang LM, Hay R, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. Oncogene. 2005 Jan 6;24(1):101-6. doi: 10.1038/sj.onc.1208181. Oncogene. 2005. PMID: 15531925

6

Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.

Gao CF, Xie Q, Zhang YW, Su Y, Zhao P, Cao B, Furge K, Sun J, Rex K, Osgood T, Coxon A, Burgess TL, Vande Woude GF. Gao CF, et al. Among authors: vande woude gf. Mol Cancer Ther. 2009 Oct;8(10):2803-10. doi: 10.1158/1535-7163.MCT-09-0125. Mol Cancer Ther. 2009. PMID: 19825800

7

MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.

Zhang YW, Staal B, Essenburg C, Su Y, Kang L, West R, Kaufman D, Dekoning T, Eagleson B, Buchanan SG, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. Cancer Res. 2010 Sep 1;70(17):6880-90. doi: 10.1158/0008-5472.CAN-10-0898. Epub 2010 Jul 19. Cancer Res. 2010. PMID: 20643778

8

Strengthening context-dependent anticancer effects on non-small cell lung carcinoma by inhibition of both MET and EGFR.

Zhang YW, Staal B, Essenburg C, Lewis S, Kaufman D, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. Mol Cancer Ther. 2013 Aug;12(8):1429-41. doi: 10.1158/1535-7163.MCT-13-0016. Epub 2013 May 29. Mol Cancer Ther. 2013. PMID: 23720767

9

Met receptor tyrosine kinase: enhanced signaling through adapter proteins.

Furge KA, Zhang YW, Vande Woude GF. Furge KA, et al. Among authors: vande woude gf. Oncogene. 2000 Nov 20;19(49):5582-9. doi: 10.1038/sj.onc.1203859. Oncogene. 2000. PMID: 11114738 Review.

10

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

Zhang YW, Su Y, Volpert OV, Vande Woude GF. Zhang YW, et al. Among authors: vande woude gf. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12718-23. doi: 10.1073/pnas.2135113100. Epub 2003 Oct 10. Proc Natl Acad Sci U S A. 2003. PMID: 14555767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters